The continuous activation of EGF-EGFR signalling pathway is considered as a key factor in inflammation and modulated tumour proliferation, differentiation, epithelial–mesenchymal transition and angiogenesis within HCC 26–28, although the mechanism by which EGF regulates the occurrence of inflammatory microenvironment remains unclear. Here, EGFR is linked to hepatocellular carcinoma.